The weekly litigation news digest is live. Subscribe now

IP Verse

Carsgen Therapeutics competitive analysis

Loading summary...

Latest patents of Carsgen Therapeutics opposed by its competitors

Explore Carsgen Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3445407
Dec 14, 2022Compositions And Methods Of Cellular Immunotherapy2
EP3170842
Sep 4, 2019Immunologic Effector Cell Of Targeted Cld18A2, And Preparation Method And Use Thereof1

Latest PTAB cases involving Carsgen Therapeutics

Discover the latest PTAB cases involving Carsgen Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Carsgen Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CARSGEN THERAPEUTICS - 3 - -
BIONTECH CELL & GENE THERAPIES1 - - -